XML 50 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Instruments
9 Months Ended
Sep. 30, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments
Derivative Instruments
 
The Company’s derivative instruments are primarily comprised of Swaps, which are designated as cash flow hedges against the interest rate risk associated with its borrowings. The Company has also entered into TBA short positions and Linked Transactions, both of which are not designated as hedging instruments.  The following table presents the fair value of the Company’s derivative instruments and their balance sheet location at September 30, 2013 and December 31, 2012:
 
 
 
 
 
 
 
September 30,
2013
 
September 30,
2013
 
December 31,
2012
Derivative Instrument
 
Designation 
 
Balance Sheet Location
 
Notional Amount
 
Fair Value
(In Thousands)
 
 
 
 
 
 
 
 
 
 
Linked Transactions
 
Non-Hedging
 
Assets
 
N/A

 
$
23,940

 
$
12,704

Non-cleared legacy Swaps (1)
 
Hedging
 
Assets
 
$
450,000

 
$
4,629

 
$
203

Non-cleared legacy Swaps (1)
 
Hedging
 
Liabilities
 
$
1,479,263

 
$
(31,154
)
 
$
(63,034
)
Cleared Swaps (2)
 
Hedging
 
Liabilities
 
$
2,150,000

 
$
(25,375
)
 
$

TBA short positions
 
Non-Hedging
 
Liabilities
 
N/A

 
$
(8,724
)
 
$

 
(1)  Non-cleared legacy Swaps include Swaps executed and settled bilaterally with counterparties without the use of an organized exchange or central clearing house.
(2) Cleared Swaps include Swaps executed bilaterally with a counterparty in the over-the-counter market but then novated to a central clearing house, whereby the central clearing house becomes the counterparty to both of the original counterparties.

Linked Transactions
 
The Company’s Linked Transactions are evaluated on a combined basis, reported as forward (derivative) instruments and presented as assets on the Company’s consolidated balance sheets at fair value.  The fair value of Linked Transactions reflect the value of the underlying Non-Agency MBS, linked repurchase agreement borrowings and accrued interest receivable/payable on such instruments.  The Company’s Linked Transactions are not designated as hedging instruments and, as a result, the change in the fair value and net interest income from Linked Transactions is reported in other income on the Company’s consolidated statements of operations.
 
The following tables present certain information about the Non-Agency MBS and repurchase agreements underlying the Company’s Linked Transactions at September 30, 2013 and December 31, 2012:
 
Linked Transactions at September 30, 2013
 
 
Linked Repurchase Agreements
 
Linked MBS
 
 
 
Balance
 
Weighted Average Interest Rate
 Non-Agency MBS
 
 Fair Value
 
 Amortized Cost
 
 Par/Current Face
 
Weighted Average Coupon Rate
 
 
Maturity or Repricing
 
(Dollars in Thousands)
 
 
 
 
 
(Dollars in Thousands)
 
 
 
 
 
 
 
 
 
Within 30 days
 
$
61,642

 
1.72
%
 
Rated AA
 
$
9,724

 
$
9,162

 
$
9,487

 
5.00
%
 
>30 days to 90 days
 
20,775

 
1.61

 
Rated A
 
2,654

 
2,138

 
2,793

 
1.28

 
Total
 
$
82,417

 
1.69
%
 
Rated BBB
 
7,672

 
6,730

 
8,149

 
2.31

 
 
 
 
 
 
 
Rated BB
 
6,637

 
6,177

 
6,773

 
2.56

 
 
 
 
 
 
 
Rated D
 
13,921

 
12,450

 
16,939

 
5.80

 
 
 
 
 
 
 
Rated NR
 
65,623

 
65,655

 
66,523

 
3.85
%
 
 
 
 
 
 
 
Total
 
$
106,231

 
$
102,312

 
$
110,664

 
3.99
%
 
Linked Transactions at December 31, 2012
 
 
Linked Repurchase Agreements
 
Linked MBS
 
 
 
Balance
 
Weighted Average Interest Rate
 Non-Agency MBS
 
 Fair Value
 
 Amortized Cost
 
 Par/Current Face
 
Weighted Average Coupon Rate
 
 
Maturity or Repricing
 
(Dollars in Thousands)
 
 
 
 
 
(Dollars in Thousands)
 
 
 
 
 
 
 
 
 
Within 30 days
 
$
13,672

 
1.57
%
 
Rated AA
 
$
13,588

 
$
12,817

 
$
13,192

 
5.00
%
 
>30 days to 90 days
 
21,599

 
1.66

 
Rated A
 
3,075

 
2,548

 
3,342

 
0.76

 
Total
 
$
35,271

 
1.63
%
 
Rated BBB
 
8,299

 
7,226

 
8,847

 
2.55

 
 
 
 
 
 
 
Rated BB
 
7,365

 
6,854

 
7,593

 
2.75

 
 
 
 
 
 
 
Rated D
 
15,501

 
14,372

 
19,303

 
5.80

 
 
 
 
 
 
 
Total
 
$
47,828

 
$
43,817

 
$
52,277

 
4.28
%

 
At September 30, 2013, Linked Transactions also included approximately $186,000 of associated accrued interest receivable and $60,000 of accrued interest payable.  At December 31, 2012, Linked Transactions also included approximately $185,000 of associated accrued interest receivable and $38,000 of accrued interest payable.
 
The following table presents certain information about the components of the unrealized net gains and net interest income from Linked Transactions included in the Company’s consolidated statements of operations for the three and nine months ended September 30, 2013 and 2012:
 
Components of Unrealized Net Gains and Net Interest Income
from Linked Transactions
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
(In Thousands)
 
2013
 
2012
 
2013
 
2012
Interest income attributable to MBS underlying Linked Transactions
 
$
1,109

 
$
812

 
$
2,431

 
$
4,386

Interest expense attributable to linked repurchase agreement borrowings underlying Linked Transactions
 
(275
)
 
(168
)
 
(552
)
 
(965
)
Change in fair value of Linked Transactions included in earnings
 
(290
)
 
2,533

 
(94
)
 
8,023

Unrealized net gains and net interest income from Linked Transactions
 
$
544

 
$
3,177

 
$
1,785

 
$
11,444


 
Swaps
 
Consistent with market practice, the Company has agreements with its Swap counterparties that provide for the posting of collateral based on the fair values of its derivative contracts.  Through this margining process, either the Company or its derivative counterparty may be required to pledge cash or securities as collateral.  In addition, Swaps novated to and cleared by a central clearing house are subject to initial margin requirements. Certain derivative contracts provide for cross collateralization with repurchase agreements with the same counterparty.
 
A number of the Company’s Swap contracts include financial covenants, which, if breached, could cause an event of default or early termination event to occur under such agreements.  Such financial covenants include minimum net worth requirements and maximum debt-to-equity ratios.  If the Company were to cause an event of default or trigger an early termination event pursuant to one of its Swap contracts, the counterparty to such agreement may have the option to terminate all of its outstanding Swap contracts with the Company and, if applicable, any close-out amount due to the counterparty upon termination of the Swap contracts would be immediately payable by the Company.  The Company was in compliance with all of its financial covenants through September 30, 2013.  At September 30, 2013, the aggregate fair value of assets needed to immediately settle Swap contracts that were in a liability position to the Company, if so required, was approximately $59.2 million, including accrued interest payable of approximately $2.6 million.
 
The following table presents the assets pledged as collateral against the Company’s Swap contracts at September 30, 2013 and December 31, 2012:
 
(In Thousands)
 
September 30, 2013
 
December 31, 2012
Agency MBS, at fair value
 
$
67,255

 
$
68,915

Restricted cash
 
59,275

 
5,016

Total assets pledged against Swaps
 
$
126,530

 
$
73,931


 
The use of derivative hedging instruments exposes the Company to counterparty credit risk.  In the event of a default by a derivative counterparty, the Company may not receive payments to which it is entitled under its derivative agreements, and may have difficulty recovering its assets pledged as collateral against such agreements.  If, during the term of a derivative contract, a counterparty should file for bankruptcy, the Company may experience difficulty recovering its assets pledged as collateral which could result in the Company having an unsecured claim against such counterparty’s assets for the difference between the fair value of the derivative and the fair value of the collateral pledged to such counterparty.  At September 30, 2013, all of the Company’s derivative counterparties were rated A or better by a Rating Agency.
 
The Company’s derivative hedging instruments, or a portion thereof, could become ineffective in the future if the associated repurchase agreements or securitized debt that such derivatives hedge fail to exist or fail to have terms that match those of the derivatives that hedge such borrowings.  At September 30, 2013, all of the Company’s derivatives were deemed effective for hedging purposes and no derivatives were terminated during the three and nine months ended September 30, 2013 and 2012.
 
The Company’s Swaps have the effect of modifying the repricing characteristics of the Company’s repurchase agreements and securitized debt and cash flows for such liabilities.  To date, no cost has been incurred at the inception of a Swap (except for certain transaction fees related to entering in to Swaps cleared though a central clearing house), pursuant to which the Company agrees to pay a fixed rate of interest and receive a variable interest rate, generally based on one-month or three-month London Interbank Offered Rate (“LIBOR”), on the notional amount of the Swap. The Company has not recognized any change in the value of its derivative hedging instruments in earnings as a result of the hedge or a portion thereof being ineffective during the three and nine months ended September 30, 2013 and 2012.
 
At September 30, 2013, the Company had Swaps with an aggregate notional amount of $4.079 billion, which had net unrealized losses of $51.9 million, and extended 51 months on average with a maximum term of approximately 9.94 years

The following table presents certain information with respect to the Company's Swap activity during the three and nine months ended September 30, 2013:

(Dollars in Thousands)
 
Three Months Ended 
 September 30, 2013
 
Nine Months Ended 
 September 30, 2013
New Swaps:
 
 
 
 
Aggregate notional amount
 
$
1,750,000

 
$
2,501,000

Weighted average fixed-pay rate
 
2.13
%
 
1.85
%
Initial maturity date
 
Five years to ten years

 
Two months to ten years

Number of new Swaps
 
14

 
23

Swaps amortized/expired:
 
 
 
 
Aggregate notional amount
 
$
358,012

 
$
941,300

Weighted average fixed-pay rate
 
4.16
%
 
2.73
%


The following table presents information about the Company’s Swaps at September 30, 2013 and December 31, 2012:
 
 
 
 
September 30, 2013
 
December 31, 2012
 
 Notional Amount
 
Weighted Average Fixed-Pay Interest Rate
 
Weighted Average Variable Interest Rate (2) 
Notional Amount 
 
Weighted Average Fixed-Pay Interest Rate
 
 Weighted Average Variable Interest Rate (2)
 
 
Maturity (1)
 
(Dollars in Thousands)
 
 
 
 
 
 
 
 
 
 
 
 
 
Within 30 days
 
$
14,509

 
4.02
%
 
0.23
%
 
$
25,828

 
3.88
%
 
0.28
%
 
Over 30 days to 3 months
 
19,542

 
4.16

 
0.21

 
30,185

 
3.96

 
0.26

 
Over 3 months to 6 months
 
41,851

 
3.92

 
0.23

 
527,275

 
1.63

 
0.21

 
Over 6 months to 12 months
 
522,469

 
1.90

 
0.18

 
391,063

 
4.17

 
0.22

 
Over 12 months to 24 months
 
830,892

 
2.17

 
0.19

 
685,042

 
2.28

 
0.22

 
Over 24 months to 36 months
 
50,000

 
2.13

 
0.18

 
710,171

 
1.97

 
0.21

 
Over 36 months to 48 months
 
450,000

 
0.56

 
0.18

 
150,000

 
1.03

 
0.21

 
Over 48 months to 60 months
 
550,000

 
1.49

 
0.18

 

 

 

 
Over 60 months to 72 months
 

 

 

 

 

 

 
Over 72 months to 84 months
 
1,500,000

 
2.22

 
0.18

 

 

 

 
Over 84 months (3)
 
100,000

 
2.75

 
0.18

 

 

 

 
Total Swaps
 
$
4,079,263

 
1.93
%
 
0.18
%
 
$
2,519,564

 
2.31
%
 
0.22
%

(1)  Each maturity category reflects contractual amortization and/or maturity of notional amounts.
(2)  Reflects the benchmark variable rate due from the counterparty at the date presented, which rate adjusts monthly or quarterly based on one-month or three-month LIBOR, respectively.
(3) Reflects one Swap with a maturity date of July 2023.
 
The following table presents the net impact of the Company’s derivative hedging instruments on its interest expense and the weighted average interest rate paid and received for such Swaps for the three and nine months ended September 30, 2013 and 2012:
 
 
 
Three Months Ended 
 September 30,
 
Nine Months Ended 
 September 30,
(Dollars in Thousands)
 
2013
 
2012
 
2013
 
2012
Interest expense attributable to Swaps
 
$
15,888

 
$
18,138

 
$
40,884

 
$
58,275

Weighted average Swap rate paid
 
2.07
%
 
2.72
%
 
2.15
%
 
2.74
%
Weighted average Swap rate received
 
0.20
%
 
0.27
%
 
0.20
%
 
0.29
%

 
Impact of Derivative Hedging Instruments on AOCI
 
The following table presents the impact of the Company’s derivative hedging instruments on its AOCI for the three and nine months ended September 30, 2013 and 2012:
 
 
 
Three Months Ended 
 September 30,
 
Nine Months Ended 
 September 30,
(In Thousands)
 
2013
 
2012
 
2013
 
2012
AOCI from derivative hedging instruments:
 
 
 
 
 
 
 
 
Balance at beginning of period
 
$
(31,967
)
 
$
(89,823
)
 
$
(62,831
)
 
$
(114,194
)
Unrealized (loss)/gain on Swaps, net
 
(19,934
)
 
11,654

 
10,930

 
36,025

Balance at end of period
 
$
(51,901
)
 
$
(78,169
)
 
$
(51,901
)
 
$
(78,169
)

 
Counterparty Credit Risk
 
By using derivative hedging instruments, the Company is exposed to counterparty credit risk if counterparties to the derivative contracts do not perform as expected.  If a counterparty fails to perform, the Company’s counterparty credit risk is equal to the amount reported as a derivative asset on its consolidated balance sheets to the extent that amount exceeds collateral obtained from the counterparty or, if in a net liability position, the extent to which collateral posted exceeds the liability to the counterparty.  The amounts reported as a derivative asset/(liability) are derivative contracts in a gain/(loss) position, and to the extent subject to master netting arrangements, net of derivatives in a loss/(gain) position with the same counterparty and collateral received/(pledged).  The Company attempts to minimize counterparty credit risk through credit approvals, limits, monitoring procedures, executing master netting arrangements and obtaining collateral, where appropriate.  Counterparty credit risk related to the Company’s derivative hedging instruments is considered in determining fair value of such derivatives and its assessment of hedge effectiveness.

TBA Short Positions

The Company may also enter into TBA short positions as a means of managing interest rate risk and MBS basis risk associated with its investment and financing activities. A TBA short position is a forward contract for the sale of agency MBS at a predetermined price, face amount, issuer, coupon and stated maturity on an agreed-upon future date. The specific agency MBS that could be delivered into the contract upon the settlement date, published each month by SIFMA, are not known at the time of the transaction.

The Company accounts for TBA short positions as derivative instruments since it cannot assert that it is probable at inception and throughout the term of the TBA contract that it will physically deliver the agency security upon settlement of the contract. The Company presents TBA short positions as either assets or liabilities in Other derivative instruments, at fair value on its consolidated balance sheets. Gains and losses associated with TBA Securities are reported in Other income on the Company's consolidated statements of operations.

The following table presents the Company's TBA short positions as of September 30, 2013 and December 31, 2012:

 
 
September 30, 2013
 
December 31, 2012
(In Thousands)
 
Principal
 
Cost
Basis (1)
 
Fair
Value (2)
 
Net Carrying Value (3)
 
Principal
 
Cost
Basis (1)
 
Fair
Value (2)
 
Net Carrying Value (3)
TBA short positions
 
$
350,000

 
$
343,436

 
$
352,160

 
$
(8,724
)
 
$

 
$

 
$

 
$

 
(1) Cost basis represents the forward price to be received for the underlying agency security.
(2) Fair value represents the current fair value of the underlying agency security as of period-end.
(3) Net carrying value represents the difference between the fair value of the underlying agency security as of period-end and the cost basis and is reported in Other derivative instruments, at fair value in the Company's consolidated balance sheets. Gains and losses associated with TBA short positions are reported in Other income on the Company's consolidated statement of operations.